Welcome to LookChem.com Sign In|Join Free

CAS

  • or

854107-47-4

Post Buying Request

854107-47-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

854107-47-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 854107-47-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,4,1,0 and 7 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 854107-47:
(8*8)+(7*5)+(6*4)+(5*1)+(4*0)+(3*7)+(2*4)+(1*7)=164
164 % 10 = 4
So 854107-47-4 is a valid CAS Registry Number.

854107-47-4Relevant articles and documents

2-Imino-thiazolidin-4-one derivatives as potent, orally active S1P 1 receptor agonists

Bolli, Martin H.,Abele, Stefan,Binkert, Christoph,Bravo, Roberto,Buchmann, Stephan,Bur, Daniel,Gatfield, John,Hess, Patrick,Kohl, Christopher,Mangold, Céline,Mathys, Boris,Menyhart, Katalin,Müller, Claus,Nayler, Oliver,Scherz, Michael,Schmidt, Gunther,Sippel, Virginie,Steiner, Beat,Strasser, Daniel,Treiber, Alexander,Weller, Thomas

scheme or table, p. 4198 - 4211 (2010/09/18)

Sphingosine-1-phosphate (S1P) is a widespread lysophospholipid which displays a wealth of biological effects. Extracellular S1P conveys its activity through five specific G-protein coupled receptors numbered S1P1 through S1P5. Agonists of the S1P1 receptor block the egress of T-lymphocytes from thymus and lymphoid organs and hold promise for the oral treatment of autoimmune disorders. Here, we report on the discovery and detailed structure-activity relationships of a novel class of S1P1 receptor agonists based on the 2-imino-thiazolidin-4-one scaffold. Compound 8bo (ACT-128800) emerged from this series and is a potent, selective, and orally active S1P1 receptor agonist selected for clinical development. In the rat, maximal reduction of circulating lymphocytes was reached at a dose of 3 mg/kg. The duration of lymphocyte sequestration was dose dependent. At a dose of 100 mg/kg, the effect on lymphocyte counts was fully reversible within less than 36 h. Pharmacokinetic investigation of 8bo in beagle dogs suggests that the compound is suitable for once daily dosing in humans.

5-(BENZ- (Z) -YLIDENE) -THIAZOLIDIN-4-ONE DERIVATIVES AS IMMUNOSUPPRESSANT AGENTS

-

Page/Page column 26; 33, (2008/06/13)

The invention relates to pharmaceutical compositions containing at least one 5- (benz- (Z) -ylidene-thiazolidin-4-one derivative (I), to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thi

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 854107-47-4